FDA Approves New Absorbable Heart Stent Tested at Scripps

Scripps Clinic cardiologist Paul Teirstein, MD, weighed in on a new absorbable stent recently cleared for commercial use by the Food and Drug Administration in an article published by the San Diego Union-Tribune.

Dr. Teirstein, who is medical director of the Prebys Cardiovascular Institute, oversaw the testing of the Absorb bioresorbable vascular scaffold system among Scripps cardiology patients.

Read the Union-Tribune article: FDA Approves Potentially ‘Revolutionary’ Heart Stent.